TGFB1 and colorectal carcinoma: A similar finding was reported in another study using antibodies against TGFβ and PD-L1, which inactivated the fibroblastic TGFβ pathway and profoundly inhibited tumor growth in murine mammary and colorectal carcinoma models.131